Contraceptives: Market Research Report

Date: November 1, 2012
Pages: 524
Price:
US$ 4,950.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C925E2A2259EN
Leaflet:

Download PDF Leaflet

Contraceptives: Market Research Report
This report analyzes the worldwide markets for Contraceptives in US$ Million by the following Product Segments: Oral Contraceptives, Condoms, Implants/ Injections, and Others.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2010 through 2018.

A six-year historic analysis is also provided for these markets.

The report profiles 123 companies including many key and niche players such as Ansell Limited, Condomi Health International GmbH, Bayer HealthCare Pharmaceuticals, Church & Dwight Co. Inc., Conceptus, Inc., Female Health Company, Fuji Latex Co Ltd., HLL Lifecare Limited, Johnson & Johnson, Janssen Pharmaceuticals Inc., Merck & Co., Inc., Okamoto Industries, Inc., Reckitt Benckiser Group Plc, Teva Pharmaceutical Industries Limited, Warner Chilcott plc, and Pfizer Inc.

Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based upon search engine sources in the public domain.
I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Oral Contraceptives
Condoms
Implants/Injections
Other Contraceptives

II. EXECUTIVE SUMMARY

1.INDUSTRY OVERVIEW

A Primer
Contraceptives Market: Quick Facts
Outlook
Growth Drivers
Challenges
Impact of Recession: An Unequivocal Review
Cooling Economy Induces Changes in Childbearing Trends
Recession Adds Fuel to Cost/Affordability Challenge
Rising Preference for Surgical Family Planning Procedures
Contraceptives among Women: Scenario in the Developing World

Table 1. Contraceptives Market in Developing World (2012): Percentage Breakdown of Unintended Pregnancies by Contraceptive Usage Trend (includes corresponding Graph/Chart)
Table 2. Capability of Modern Contraception in Mitigating Mortality by Unintended Pregnancies in Developing Countries (2012) (includes corresponding Graph/Chart)

Other Trends & Issues
Consolidation to Guide New Entrants into the Contraceptives Market
Increasing Awareness Over STDs to Create Additional Demand for Condoms
HIV Prevalence and Incidence Statistics

Table 3. Global Prevalence of HIV Infection in 2010 by Region (in Millions) (includes corresponding Graph/Chart)
Table 4. Newly Infected HIV Population in 2010 by Region (in Millions) (includes corresponding Graph/Chart)
Table 5. Global HIV Related Deaths in 2010 by Region in Millions (includes corresponding Graph/Chart)
Table 6. Global HIV Prevalence among Adults and Youth (Male and Female) By Region: 2010

Multifunctional Modern Contraceptives Make a Foray
Skin Sprays: A Novel Way of Contraception
Extensive Distribution Drives growth of Contraceptive Products
Public Health Organizations Spur Condoms Use
USAID Worldwide Shipments of Condoms and Other Contraceptives

Table 7. USAID Shipments of Condoms and Contraceptives Worldwide (2011): Percentage Share Breakdown of Unit Shipments by Type - Male Condoms, Female Condoms and Oral Contraceptives
Table 8. USAID Shipments of Condoms and Other Contraceptives Worldwide (2010): Percentage Share Breakdown of Value Shipments by Region -Africa, Asia/Near East, Caribbean/Latin America and Europe/Eurasia (includes corresponding Graph/Chart)
Table 9. Global USAID Shipments of Condoms and Other Contraceptives (2010): Percentage Share Breakdown of Value Shipments by Type -Condoms, Injectables, Orals, Implants and IUDs (includes corresponding Graph/Chart)
Table 10. USAID Shipments of Condoms and Other Contraceptives Worldwide (2010): Percentage Share Breakdown of Value Shipments by Program Type -Parastatal/Governmental, Social Marketing, NGO and Research (includes corresponding Graph/Chart)

Latex Supply Woes Impact the Condoms Market
Advertising for Contraceptives Acquires A Whole New Dimension
Emergency Contraception Receives Encouragement from Government
Manufacturers & Retailers Work in Sync to Accelerate Sales
Competition in the Contraceptives R&D Market to Intensify

Table 11. Global Contraceptives Market (2010): Percentage Breakdown of Product Share in the R&D Pipeline by Stage of Clinical Trial (includes corresponding Graph/Chart)

Innovation Keeps the Fire Burning for the Condoms Market
Generic & Biosimilar Contraceptive Products Gain Ground
Generics Manufacturers
OTC Hormonal Contraceptives – An Attractive Market
Oral Contraceptives – A Painless Panacea for Prevention of Unwanted Pregnancy
R&D Companies & Generic Manufacturers - Developing Countries
Commercial Success of R&D Brands Sustain Developmental Programs in Developing Countries
Challenges Facing Generic Contraceptive Products Manufacturers

2.PRODUCT OVERVIEW

Types of Contraception
The Contraceptive Timeline
By Function
Barrier Contraceptives
Characteristic Features of Barrier Methods
Hormonal Contraceptives
Prescription Contraceptives
Oral Contraceptives
Overview of Oral Contraceptives - Benefits vs. Risks
Usage Levels of OCs in Worldwide Scenario
Traditional and Modern
Reversible and Permanent
Birth Control Methods and their Use in Major Regions Worldwide
Contraception - Levels of Effectiveness
Effectiveness Index of Contraceptive Measures
Unmet Need for Contraception
Segmental Analysis
A. Condoms
Overview
Categories
Latex Condoms
Non-Latex Condoms
Skin Condoms
Polyurethane (PU) Condoms
Comparison Between Polyurethane & Latex Condoms
Male Condom - Effectiveness of Protection Against STDs
Myths & Facts
Selection & Effective Use of Condoms
Highlights
Growth Factors
Factors Hindering Wide Spread Use of Condoms
Measures Aimed at Increasing Usage
Female Condoms
Who are the Main Users?
Reality – An Effective Female Condom
B. Oral Contraceptives (OCs)/Pills
A Peep into the Past
Synthetic Oral Contraceptives
Characteristic Features of Oral Contraceptives (OCs)
Bayer Schering Pharma’s “Yasmin”: A Resounding Brand Worldwide
Advantages of Using OCs
Effects of Long-Term Use of OCs
Use of OCs/Pills - Myths & Facts
Oral Contraceptives - Challenges & Strategies to Overcome Problems
Factors Associated with Failure of OCs/Pills
Health Conditions to be Addressed when Using OCs
Understanding Risks Associated with Use of OCs
Cardiovascular Disease – A Major Side Effect of OCs
Intake of OCs Result in High Blood Pressure
Smoking Intensifies Respiratory Problems in Pill Users
Age Related Complications Associated with the Direct Use of OCs
Relation Between OC and Cancer
Depression Linked to Use of OCs
OCs Increases Osteoporosis Risk at Later Stage
OCs May Reduce Sex Drive
Effects of Pill on Childbearing Capacity
Visiting a Doctor – Highly Recommended in Case of Warning Symptoms
Emergency Contraception (EC) – A New Face of OCs
Role of ECPs
Effectiveness of ECP
Different Types of EC Products
Mini Pills
RU486 - the French Abortion Pill
Availability of Hormonal Contraceptives as OTC Drugs
C. Injectable Contraceptives
Depo-Provera
Characteristic Features of Injectable Contraceptives
Injectables - Challenges & Strategies to Overcome Problems
D. Intrauterine Devices (IUDs)/Implants
Product Categories
CopperT 380A (ParaGard)
Progesterone T (or Progestasert)
Characteristic Features
Benefits
Side Effects
Challenges & Strategies to Overcome Problems
Long-term Reversible Contraceptive Implants
Products
Norplant
Implanon
Mirena
Characteristic Features of Implantable Contraceptives
Challenges & Strategies to Overcome Problems
E. Spermicides
Product Categories
Benefits
Drawbacks
Contraceptive Foam
Delfen Contraceptive Foam
Contraceptive Cream or Jelly
Encare Ovals

Table 12. Effectiveness in Prevention of Pregnancy - Condom and Spermicide, Condom Alone and Spermicide Alone (includes corresponding Graph/Chart)

F. Diaphragms
G. Withdrawal & Douching
H. Sterilization
Tubal Ligation
Reasons Behind Adoption
Risk of Complications
Types
Abdominal Procedures
Laparoscopy
Mini-Laparotomy
Laparotomy
Vaginal Procedures
Culdoscopy
Colpotomy
Hysterectomy – A High Risk Surgery
Selective Tubal Occlusion Procedure (STOP)
Vasectomy
Method of Working
Reasons Behind Adoption
Risk of Complications
I. Other Contraceptive Methods
Contraceptive Sponges
Today Sponge
Characteristic Features of Today Sponge

Table 13. Efficiency Rates of Today Sponge Based on Usage for 12-Month Period (includes corresponding Graph/Chart)

Protectaid Sponge
Characteristic Features of Protectaid Sponge
Cervical Caps
Pros and Cons of the Device
Vaginal Contraceptive Film (VCF)
Contraceptive Vaccine
Ortho Evra Weekly Contraceptive Patch
NuvaRing Monthly Vaginal Ring

3.RESEARCH AND DEVELOPMENT

Oral Contraceptive Minimizes Premenstrual Syndrome Symptoms as per New Study
Cause of Infertility - Not Associated with IUDs
Presence of Estrogen in OCs Offers Protection from Colorectal Cancer
Hormonal Contraceptive Usage & Risk Associated with Certain STDs
Use of Third Generation Ocs Increases Risk of Blood Clots
High Risk of Deep Vein Thrombosis with Cyproterone- Containing OCs

4.ROLE OF UNITED NATIONS IN PROMOTING USE OF CONTRACEPTIVES

Female Condoms Reach New Heights with Aid from UNAIDS
Donor Support for Contraceptive Commodity

Table 14. Total Cost of Contraceptives and Condoms: 2000-2010 (In US$ Million) (includes corresponding Graph/Chart)

Unmet Need
Urgent Need for Use of Modern Contraceptives

Table 15. Penetration of Modern Contraceptives in Developing Regions for Women in Reproductive Age by Need (2011) (includes corresponding Graph/Chart)
Table 16. Usage of Modern Contraceptive by Women in Developing Countries (2012): Percentage Breakdown by Type (includes corresponding Graph/Chart)

Use of Modern Contraceptives Grows in Developing Regions

Table 17. Estimated Numbers of Contraceptive Users in Developing Nations: 2000-2015 (In Millions) (includes corresponding Graph/Chart)
Table 18. Percentage Penetration of Modern Contraceptives by Married Women by Region/ Country (2011) (includes corresponding Graph/Chart)
Table 19. Capability of Modern Contraception in Mitigating Mortality by Unintended Pregnancies in Developing Countries (2012) (includes corresponding Graph/Chart)

Difference in Usage of Oral contraceptives in Developed and Developing World
Prevalence of Contraceptive Methods

Table 20. Worldwide Contraceptives Market: Estimated Number of Users (2015 & 2025) - Asia, Latin America and Africa (In Millions) (includes corresponding Graph/Chart)
Table 21. Worldwide Contraceptive Market: Prevalence in Women (2000-2025) - Percentage Share by Asia, Latin America and Africa (includes corresponding Graph/Chart)

United Nations Population Fund (UNFPA)
UNFPA Gets Aid from Britain to Help Developing World
Rise in Cost of Providing Contraceptives
Future Trends Worldwide

5.NEW PRODUCT INTRODUCTIONS/ INNOVATIONS

Watson Pharmaceuticals Introduces Vestura an Oral Contraceptive
Ansell Unveils SKYN® Condom in Brazil and China
Vystar® and Ritex Gummiwarenfabrik to Launch Ritex Silver-Light Condoms
Bayer HealthCare Pharmaceuticals Introduces Qlaira® Oral Contraceptive
The Female Health Offers La Luna Female Condoms in Israel
Merck & Co Introduces NEXPLANON 68mg
Watson Pharmaceuticals Introduces Generess™ Fe
WomanCare Global Includes Essure® to Product Portfolio
LifeStyles Introduces SKYN® Large
Acme Brasil Introduces Condoms under the Unique by Natural Sensation®
Conceptus Launches Essure FlexPayTM Financial Assistance Plan
Lupin Pharmaceuticals Introduces Generic Femcon Fe Chewable Tablets in US
Hyundai Pharm and HRA Pharma Roll Out ellaOne in South Korea
Futura Develops CSD500

6.PRODUCT INNOVATIONS/INTRODUCTIONS IN THE RECENT PAST - A PERSPECTIVE BUILDER

Watson Pharmaceuticals Rolls Out ella Oral Emergency Contraceptive
HLL Lifecare to Launch Pan Flavoured Condoms
Glenmark Generics Receives USFDA Approval for Norethindrone Tablets
HLL Lifecare to Introduce Moods in Australian Markets
Organon Releases Contraceptive NuvaRing
HRA Pharma Unveils ellaOne
Bayer Introduces Qlaira New Oral Contraceptive
Durex Introduces Avanti Bare™
Teva to Introduce Tri-Lo Sprintec
Teva Announces Launch of Topiramate Tablets
Duramed Releases LoSEASONIQUE
Uganda Health Marketing Group Rolls Out NewFem, A New Contraceptive Pill
TTK LIG to Unveil Durex Jeans Condoms
Teva Pharmaceutical Industries Receives Approval for Plan B One-Step Emergency Contraceptive
Cupid Limited to Unveil Cost-effective Female Condoms
Bayer Schering Pharma Launches QlairaA®
Watson Laboratories Secures USFDA Approval for Plan B OTC Generics
Organon Launches Vaginal Contraceptive Ring

7.RECENT INDUSTRY ACTIVITY

Ansell Takes Over Trelleborg Protective Products Operations
Bayer HealthCare Partners with USAID to Launch Microgynon Fe Contraceptive
DKT International to Distribute Contraceptives in Ghana
Conceptus Obtains FDA Approval for Inclusion of 10-Year Data for Essure® Procedure
Conceptus Secures FDA Approval for Label Changes Related to Compatible Usage of NovaSure® with Essure
Lupin Receives FDA Approval for Generic Variant of Ortho Tri-cyclen Lo Oral Contraceptive
Glenmark Generics US Receives FDA Approval for Ethinyl Estradiol and Norgestimate Tablets
Bayer HealthCare Pharmaceuticals Receives FDA Approval for NataziaTM
Teva Receives FDA Approval for Quartette™, An Oral Contraceptive for Females
Agile Therapeutics Receives FDA Approval for AG200-15, Contraceptive Patch
The Female Health Company Established Two New Production Lines In Malaysia
Glenmark Receives Approval for its Viorele, an Oral Contraceptive for Women
Watson Pharmaceuticals Receives USFDA Approval for Beyaz
Bayer Files for EU Approval for the Company’s Birth Control Patch
J&J ‘s Ortho Evra, Birth Control Patch Receives FDA Approval
Pfizer Recalls Norgestrel/Ethinyl Estradiol Tablets and Lo/Ovral®-28 Tablets from US
Savanna East Africa Acquires Kenyan Condom Producer in Kenya
Ansell Takes Over Minority Stake in Yulex
Ortho-McNeil and PriCara to Operate Under Janssen Pharmaceuticals
Conceptus Acquires Distribution Rights to Essure Device
Sosei Receives Approval for NorLevo Tablets by Japan Ministry of Health, Labour and Welfare
Starpharma Holdings Inks Licensing Agreement with Ansell
Starpharma Holdings Enters into Agreement with Okamoto
Female Health Company Receives Supply Order from British Government

8.CORPORATE ACTIVITY IN THE RECENT PAST – A PERSPECTIVE BUILDER

WomanCare Global Acquires Roselle and Optinor from Icon
Teva Signs Deal to Acquire Theramax
Ferring Pharmaceuticals Purchases Lysteda from Xanodyne Pharmaceuticals
NextPharma Technologies Expands Waltrop Semi-Solids Hormones Facility
Reckitt Benckiser Acquires SSL International
Warner Chilcott and Lupin Pharmaceuticals Ink Settlement Agreement
FHC Bags Order to Supply 3.5 Million FC2 Female Condoms for 2010 World Cup in South Africa
SSL Acquires Majority Stake in BLBV
Columbia Laboratories Inks Definitive Agreement with Watson Pharmaceuticals
Piramal Healthcare Signs Definitive Agreement with Cipla
Watson Pharmaceuticals to Market HRA Pharma's Emergency Contraceptive
Lupin to Establish Three New Production Facilities
Pfizer to Purchase Wyeth
Ansell Healthcare Signs Agreement with NYC Department of Health and Mental Hygiene
Teva Pharmaceutical Industries' Yaz Receives FDA Approval
Teva Pharmaceutical Industries' Yaz Receives Marketing Approval from FDA
Watson Pharmaceuticals, Warner Chilcott Collaborate for Femring
Watson Pharmaceuticals Inks Agreement with Warner Chilcott for WC3026
Merck Merges with Schering-Plough
Vystar Inks Agreement with Centrotrade Minerals and Metals and Centrotrade Deutschland
Mayer Laboratories Signs Agreement with Alvogen Group
Hypermarcas Acquires Inal
Sosei Inks Distribution Agreement with ASKA Pharmaceuticals
Sanofi-Aventis to Construct Plant in Brazil
Durex Chinese Plant Starts Production
Patheon Expands Toronto Plant
Female Health Co Receives FDA Approval for Cheaper Female Condom

9.FOCUS ON SELECT GLOBAL PLAYERS

Ansell Limited (Australia)
Condomi Health International GmbH (Germany)
Bayer HealthCare Pharmaceuticals (Germany)
Church & Dwight Co., Inc. (US)
Conceptus Inc (US)
Female Health Company (US)
Fuji Latex Co Ltd (Japan)
HLL Lifecare Limited (India)
Johnson & Johnson (US)
Janssen Pharmaceuticals Inc. (US)
Merck & Co., Inc (USA)
Okamoto Industries Inc (Japan)
Reckitt Benckiser Group Plc (UK)
Teva Pharmaceutical Industries Limited (Israel)
Warner Chilcott plc (Ireland)
Pfizer Inc (USA)

10.GLOBAL MARKET PERSPECTIVE

Table 22. World Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 23. World Historic Review for Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 24. World 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
Table 25. World Recent Past, Current & Future Analysis for Oral Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 26. World Historic Review for Oral Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 27. World 15-Year Perspective for Oral Contraceptives by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
Table 28. World Recent Past, Current & Future Analysis for Condoms by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 29. World Historic Review for Condoms by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 30. World 15-Year Perspective for Condoms by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
Table 31. World Recent Past, Current & Future Analysis for Implants/Injections by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 32. World Historic Review for Implants/Injections by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 33. World 15-Year Perspective for Implants/ Injections by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
Table 34. World Recent Past, Current & Future Analysis for Other Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 35. World Historic Review for Other Contraceptives by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 36. World 15-Year Perspective for Other Contraceptives by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

III. MARKET

1.THE UNITED STATES

A. Market Analysis
Outlook
Restraints
Are Women's Reproductive Rights Getting Axed on the New Health Care Bill?
Medicaid Coverage For Family Planning
Regulations Encouraging Access to Emergency Contraceptives
Major Market Trends
Generics Pitted Against Branded in the Oral Contraceptives Market
Changing Consumer Demographics
Relentless Promotional Programs Drive Home the Point
Use of Intimacy Products on the Rise
Generics Ransack the Branded Market
Condoms - A ‘Fun, Inviting and Pleasurable’ Way to Healthy Life and Lifestyle
Market Share Statistics

Table 37. Leading Players in the US Male Contraceptives Market (2011): Percentage Breakdown of Sales for Church and Dwight Co., Reckitt Benckiser, Ansell, Global Protection, Mayer Labs, Majestic Drug Co., Private label and Others (includes corresponding Graph/Chart)
Table 38. US Market for Condoms by Leading Players (2011): Market Share Breakdown for Church & Dwight, Reckitt Benckiser, Ansell America, and Others (includes corresponding Graph/Chart)
Table 39. Leading Brands in the US Condom Market (2011): Percentage Share Breakdown by Sales (includes corresponding Graph/Chart)
Table 40. US Condoms Market: Percentage Breakdown of Dollar Sales by Product Type for the Year Ended January 2006 (includes corresponding Graph/Chart)
Table 41. Leading Female Contraceptive Manufacturers in the US (2011): Percentage Breakdown of Market Share for Duramed Pharmaceuticals, Watson Pharmaceuticals, Coldwell Consumer Health, Apothecus and Others (includes corresponding Graph/Chart)
Table 42. Leading Brands in the Female Contraceptives Market in the US (2009): Percentage Breakdown of Market Share for Plan B, VCF, Ortho Options Conceptrol, Encare, Ortho Options Gynol II and Others (includes corresponding Graph/Chart)

Noticeable Shift in Retail Marketing Techniques
Rising Use of Condoms Amongst Teenagers
Changing Attitudes and Perceptions Drive Market Sales

Table 43. Contraceptive Usage (Methods) and Non-Usage among Women Aged 15-44 Years in the US (2011) (includes corresponding Graph/Chart)

Elimination of Co-pays to Boost Contraceptive Sales
Pill Continues to be One of the Most Popular Forms of Contraception

Table 44. Usage Trends of Select Contraceptive Methods Among Women Aged 15-44 Years in the US (2011): Percentage Breakdown by Marital Status (includes corresponding Graph/Chart)
Table 45. Female Contraception in the US (2011): Percentage Breakdown of Usage of Pill or Sterilization Method by Age Group (includes corresponding Graph/Chart)
Table 46. Leading Birth Control Pill Brands in the US (2011): Percentage Breakdown of Market Share for Yaz, Tri-Sprintec, Ocella, Loestrin 24 Fe, NuvaRing, Sprintec, Trinessa, Aviane, Ortho Tri-Cyclen Lo and Others (includes corresponding Graph/Chart)

Oral Contraceptives Gain Ground in the US

Table 47. Leading Birth Control Pill Manufacturers in the US (2010): Percentage Breakdown of Market Share for Duramed Pharmaceuticals, Watson Pharmaceuticals Inc., Caldwell Consumer Health L.L.C., Apothecus Inc. and Others (includes corresponding Graph/Chart)

Oral Contraceptives and its Shades of Grey
Marketing Efforts Aimed at Influencing Female College Students
Condoms Continuing Canter
Drug Stores Remain the Choice for Contraceptive Needs
Trade Class Statistics
Oral Contraceptives – Unanimously the Choice of American Women

Table 48. Contraceptive Features Preferred by Women in US (includes corresponding Graph/Chart)

Health Facts
Rising Use of Oral Contraceptives
Abortion Control Drugs & Methods
Medical Abortion
a. Mifepristone - A Medical Breakthrough
b. Methotrexate
Expanding the Use & Availability of EC Drugs
Pharmacies Sell ECPs
Demographics
Facts and Figures
Sales of Contraceptives (Male & Female) – Family Planning Category
Insurance Coverage for Contraceptives Still in Contest
Strategic Corporate Developments
Product Innovations/Launches
Key Players
B. Market Analytics

Table 49. US Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 50. US Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 51. US 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

2.CANADA

A. Market Analysis
Scenario
Outlook
Condoms Market
Immucon Obtains US Patent for Male Contraceptive Technology
B. Market Analytics

Table 52. Canadian Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 53. Canada Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 54. Canadian 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

3.JAPAN

A. Market Analysis
Outlook
Market for Oral Contraceptives Yet to Take Off
Innovation Expected to Drive Sales
Major Issues and Trends
Domestic Products Dominate the Market
Health Care Institutions Remain Main Distribution Channels
Market Issues
Compulsory Labeling of Contraceptives
Impact of Legalization of Oral Contraceptives
Late Approval for Use of OCs in Japan
Factors Hindering Widespread Use of OCs
Condoms Market
Key Players
B. Market Analytics

Table 55. Japanese Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 56. Japanese Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 57. Japanese 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4.EUROPE

A. Market Analysis
Outlook
Condoms Market
Prejudices Pertaining to Birth Control Pills
Condoms and Other Contraceptives Market

Table 58. USAID Shipments of Condoms and Other Contraceptives to Europe and Eurasia (2010): Percentage Share Breakdown of Value Shipments by Type -Condoms, Orals, Female Condoms, IUDs and Injectables (includes corresponding Graph/Chart)

B. Market Analytics

Table 59. European Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 60. European Historic Review for Contraceptives by Contraceptives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 61. European 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
Table 62. European Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 63. European Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 64. European 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4A.FRANCE

A. Market Analysis
Outlook
Condoms Market
B. Market Analytics

Table 65. French Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 66. French Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 67. French 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4B.GERMANY

A. Market Analysis
Outlook
German Women Record Highest Usage Rate of Contraceptive Pill
Condoms Market
Key Players
B. Market Analytics

Table 68. German Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 69. German Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 70. German 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4C.ITALY

A. Market Analysis
Outlook
B. Market Analytics

Table 71. Italian Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/ Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 72. Italian Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 73. Italian 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4D.THE UNITED KINGDOM

A. Market Analysis
Outlook
Overview
UK Contraceptives Market Sails Through Recession
Changing Societal Trends
Innovations: Need of the Hour
Availability of Contraceptives
Contraceptive Injections
Emergency Contraception (EC)
Barrier Contraceptives
Major Trends and Issues
Hormone Based Products Overtake Barrier Products
Condoms Still Find Immense Favor in Britain

Table 74. Condom Usage Trends in the UK (2012): Breakdown of Usage Rate by Age and Gender (includes corresponding Graph/Chart)

Value of Condoms Declines Even as Volume Sales Increases
Role of Pharmacies in Improving Availability of Condoms and EC Drugs
Regulatory Environment
CEN Standards
Advertising and Promotion
Hormone-Based Contraceptives Restricted by Legislation
B. Market Analytics

Table 75. UK Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 76. UK Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 77. UK 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4E.SPAIN

A. Market Analysis
Current & Future Analysis
Outlook
B. Market Analytics

Table 78. Spanish Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 79. Spanish Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 80. Spanish 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4F.RUSSIA

A. Market Analysis
Outlook
B. Market Analytics

Table 81. Russian Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 82. Russian Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/ Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 83. Russian 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4G.REST OF EUROPE

A. Market Analysis
Outlook
Modern Contraceptives Usage in Eastern European Markets

Table 84. Usage Rates of Modern and Traditional Contraceptives in Developed and Developing Markets in Europe (2010)

Regional Briefs
Czech Republic
Denmark
Portugal

Table 85. Contraceptives Market in Portugal: Usage of Contraceptive Methods - Percentage Share by Condoms, OCs/Pill, Combination Method, Withdrawal and Calendar Method (includes corresponding Graph/Chart)

Poland
Sales of Contraceptives Plunges
Romania
A Glimpse of the Oral Contraceptives Market in Romania

Table 86. Leading Players in the Oral Contraceptives Market in Romania (2010): Percentage Breakdown of Value Sales for Bayer Healthcare, Gedeon Richter, Merck and Others (includes corresponding Graph/Chart)

Other Countries
Key Player
B. Market Analytics

Table 87. Rest of Europe Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 88. Rest of Europe Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 89. Rest of Europe 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

5.ASIA-PACIFIC

A. Market Analysis
Outlook
Market Primer

Table 90. Percentage Breakdown of Number of Women in the Age group of 15-49 Years Using Modern Contraceptives in Asia for 2012 by Sub-region (includes corresponding Graph/Chart)

Key USAID Statistics

Table 91. USAID Shipments of Condoms and Other Contraceptives to Asia (2010): Breakdown of Value Shipments by Country - Pakistan, Nepal, Bangladesh, Myanmar, Vietnam and Others (includes corresponding Graph/Chart)
Table 92. USAID Shipments of Condoms and Other Contraceptives to Asia (2010): Percentage Share Breakdown of Value Shipments by Type - Condoms, Orals, Injectables, IUDs and Implants (includes corresponding Graph/Chart)
Table 93. USAID Shipments of Condoms and Other Contraceptives to Asia (2010): Breakdown of Value Shipments by Program Type - Social Marketing, Parastatal/Governmental, NGO and Research (includes corresponding Graph/Chart)

Greater Need for Contraception Awareness Among Adolescents
Oral Contraceptives Hold Potential for Growth
Condoms Shortage Raise Fears of More HIV/AIDS Infections
B. Market Analytics

Table 94. Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 95. Asia-Pacific Historic Review for Contraceptives by Geographic Region - China, India and Rest of Asia-Pacific Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 96. Asia-Pacific 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)
Table 97. Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 98. Asia-Pacific Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 99. Asia-Pacific 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

5A.CHINA

Market Analysis
Overview
Current and Future Analysis
A Review of the Contraception and Birth Control Procedures in China
Poor Contraceptives Use Leads to Alarming Rise in Abortion Rates
Low Acceptance of Yaz Flex Oral Contraceptive Pill Among Women
Contraceptive Requirements
Condoms

14-YEAR BAN ON CONDOM ADVERTISING FINALLY LIFTED

Condoms Witness Increasing Demand
B. Market Analytics

Table 100. Chinese Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 101. Chinese Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 102. Chinese 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

5B.INDIA

A. Market Analysis
Overview
Current and Future Analysis
Rise in Population Fuels Growth
Family Planning, Need to Address Requirements
Pressing Need for Modern Contraceptives Awareness in India
Oral Contraceptives
Indian Women Fairly Open to the Concept of Oral Contraceptives
Free Distribution Scheme

Table 103. Percentage Breakdown of Free and Paid Condoms in India for years 2007-08 through 2011-12 (includes corresponding Graph/Chart)

Social Marketing Scheme

Table 104. Condoms Market in India (2008-2011): Percentage Breakdown of Condoms by Method of Distribution - Socially Marketed Condoms, Free Condoms and Commercially Marketed Condoms (includes corresponding Graph/Chart)

Other Initiatives by NACO

Table 105. NACO Condom Social Marketing Programme (June 2011): Sales Achievement as Compared to Sales Target (in Rs Crores) (includes corresponding Graph/Chart)

Global Brands Still Alien to Indians
Emergency Contraceptives - A Sunrise Segment

Table 106. Leading Players in the Emergency Contraception Market in India (2011): Percentage Breakdown of Market Share for Piramal Healthcare Ltd, Mankind Pharma Ltd and Others (includes corresponding Graph/Chart)

Misuse of Emergency Contraceptive - A Cause of Concern
Social Marketing Scheme (SMS)
Goli Ke Hamjoli Campaign
Contraceptives Distributed by Marketing Companies & NGOs Under Social Marketing Schemes
Condoms
Overview
Supply
Market Segments
Female Condoms Foray in Indian Market
Strategic Corporate Development
Key Players
B. Market Analytics

Table 107. Indian Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 108. Indian Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/ Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 109. Indian 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

5C.REST OF ASIA-PACIFIC

A. Market Analysis
Current and Future Analysis
A Review of Select Markets
Bangladesh
Status of HIV Infections
Indonesia
Competition Between Subsidized and Non-Subsidized Condom Sectors Increases
Rise in Contraceptive Use and Decline in Fertility Characterizes Indonesia
Pakistan
Factors Obstructing Improvement of Reproductive Health Status
Availability of Contraceptive Products/ Devices
The Philippines

Table 110. Use of Modern Contraceptive Methods in Philippines: Percentage Use of Select Contraceptive Methods Among Women in Union for the Year 2009 (includes corresponding Graph/Chart)

Vietnam
AIDS Widely Prevalent in the Country
Australia
Sri Lanka
Malaysia
Malaysia to Lead Condom Industry
Thailand
Sex Education – Need of the Hour
Strategic Corporate Developments
Product Innovations/Launch
Key Player
B. Market Analytics

Table 111. Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 112. Rest of Asia-Pacific Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 113. Rest of Asia-Pacific 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

6.LATIN AMERICA

A. Market Analysis
Outlook
Popular Contraceptives in Latin America and the Caribbean

Table 114. Percentage Breakdown of Number of Women in the Age group of 15-49 Years Using Modern Contraceptives in Latin America & the Caribbean by Sub-region (2012) (includes corresponding Graph/Chart)

Key USAID Statistics

Table 115. USAID Shipments of Condoms and Other Contraceptives to Latin America/Caribbean (2010): Percentage Share Breakdown of Value Shipments by Country - Haiti, Peru, Dominican Republic and Others (includes corresponding Graph/Chart)
Table 116. USAID Shipments of Condoms and Other Contraceptives to Latin America/Caribbean (2010): Percentage Share Breakdown of Value Shipments by Type - Condoms, Implants, Injectables, Orals and IUDs (includes corresponding Graph/Chart)
Table 117. USAID Shipments of Condoms and Other Contraceptives to Latin America/Caribbean (2010): Breakdown of Value Shipments by Program Type - Parastatal/Governmental, Social Marketing and NGO (includes corresponding Graph/Chart)

B. Market Analytics

Table 118. Latin American Recent Past, Current & Future Analysis for Contraceptives by Geographic Region- Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 119. Latin American Historic Review for Contraceptives by Geographic Region - Brazil and Rest of Latin America Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 120. Latin American 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin America Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)
Table 121. Latin American Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 122. Latin America Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 123. Latin American 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

6A.BRAZIL

A. Market Analysis
Current and Future Analysis
Contraceptives Market Grows Larger by the Day
Role of Condom Social Marketing (CSM)
New Contraceptive Companies Face Tough Competition
Product Innovations/Launch
B. Market Analytics

Table 124. Brazilian Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 125. Brazilian Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 126. Brazilian 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

6B.REST OF LATIN AMERICA

A. Market Analysis
Current and Future Analysis
A Review of Select Markets
Colombia
Dominican Republic

Table 127. Leading Condom Brands in the Dominican Republic Market (2008): Percentage Breakdown of Market Share for Pante, Durex, Te Amo, Escudo/Protector, Trojan and Others (includes corresponding Graph/Chart)

Ecuador
Guatemala
Mexico
B. Market Analytics

Table 128. Rest of Latin America Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 129. Rest of Latin America Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 130. Rest of Latin America 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

7.REST OF WORLD

A. Market Analysis
Outlook
Middle East
Socio-Cultural Factors Influencing Use of Condoms
Oral Contraceptives Usage Patterns in Near East and Africa
Jordan
Jamaica
Post Offices Playing Key Role in Improving Condom Accessibility
Africa

Table 131. Percentage Breakdown by Number of Women in the Age Group of 15-49 Years Using Modern Contraceptives in Africa for 2012 by Sub-region (includes corresponding Graph/Chart)

High Demand for Condoms in Africa

Table 132. USAID Shipments of Condoms and Other Contraceptives to Africa (2010): Breakdown of Value Shipments by Country - Malawi, Tanzania, Uganda, Ethiopia, Zimbabwe and Others (includes corresponding Graph/Chart)
Table 133. USAID Shipments of Condoms and Other Contraceptives to Africa (2010): Breakdown of Value Shipments by Type - Injectables, Male Condoms, Implants, Orals, Female Condoms and IUDs (includes corresponding Graph/Chart)
Table 134. USAID Shipments of Condoms and Other Contraceptives to Africa (2010): Breakdown of Value Shipments by Program Type -Parastatal/Governmental, Social Marketing and NGO (includes corresponding Graph/Chart)

Female Condoms Gain Ground in South Africa
Ghana
Innovative Marketing Strategies to Drive Growth in the Contraceptives Market
Uganda
Condoms – A Case of Anti-AIDS Success
Kenya
Zimbabwe
Churches in Dilemma Over Condom Use in Zimbabwe
Other Countries
Strategic Corporate Developments
Key Player
B. Market Analytics

Table 135. Rest of World Recent Past, Current & Future Analysis for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/Injections and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 136. Rest of World Historic Review for Contraceptives by Product Segment - Oral Contraceptives, Condoms, Implants/ Injections and Others Markets Segments Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 137. Rest of World 15-Year Perspective for Contraceptives by Product Segment - Percentage Breakdown of Dollar Sales for Oral Contraceptives, Condoms, Implants/ Injections and Others Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 123 (including Divisions/Subsidiaries - (140)
The United States (30)
Canada (2)
Japan (3)
Europe (31)
- France (3)
- Germany (9)
- The United Kingdom (5)
- Italy (1)
- Rest of Europe (13)
Asia-Pacific (Excluding Japan) (53)
Latin America (18)
Middle East (1)
Africa (2)
Skip to top


Ask Your Question

Contraceptives: Market Research Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: